GPAT — GP-Act III Acquisition Balance Sheet
0.000.00%
- $391.00m
- $391.29m
Annual balance sheet for GP-Act III Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | — | 0.002 | 0.001 | 0.484 | 0.113 |
| Net Total Receivables | — | — | — | — | 0.005 |
| Prepaid Expenses | |||||
| Total Current Assets | — | 0.004 | 0.003 | 0.675 | 0.188 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.288 | 1.06 | 0.53 | 297 | 309 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.267 | 1.15 | 0.628 | 0.632 | 0.635 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.267 | 1.15 | 0.628 | 14.7 | 14.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 0.021 | -0.084 | -0.098 | 283 | 295 |
| Total Liabilities & Shareholders' Equity | 0.288 | 1.06 | 0.53 | 297 | 309 |
| Total Common Shares Outstanding |